English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 4611451      線上人數 : 907
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32232


    標題: Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways
    作者: Wu, Tao-Cheng
    Chiang, Chih-Yao
    Chan, Jenq-Shyong
    Lee, Chiu-Yang
    Leu, Hsin-Bang
    Huang, Po-Hsun
    Chen, Jia-Shiong
    Lin, Shing-Jong
    Chen, Jaw-Wen
    貢獻者: Natl Yang Ming Univ, Cardiovasc Res Ctr
    Taipei Vet Gen Hosp, Div Cardiol, Dept Med
    Taipei City Hosp, Div Cardiovasc Surg
    Armed Forces Tao Yuan Gen Hosp, Div Nephrol
    Taipei Vet Gen Hosp, Div Cardiovasc Surg, Dept Surg
    Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management
    Taipei Vet Gen Hosp, Hlth Care & Serv Ctr
    Taipei Vet Gen Hosp, Dept Med Res & Educ
    Natl Yang Ming Univ, Inst Pharmacol, Inst Clin Med, Sch Med
    關鍵字: tocilizumab
    human aortic smooth muscle cells
    interleukin-6 receptor
    glucose
    diabetes
    日期: 2018-11-01
    上傳時間: 2019-11-15 15:46:05 (UTC+8)
    出版者: MARY ANN LIEBERT, INC
    摘要: Rheumatoid arthritis (RA) with diabetes increases the risk of cardiovascular diseases. Interleukin-6 (IL-6) promotes the disease activity of RA and insulin resistance. This study aimed to evaluate the potential effects and molecular mechanisms of IL-6 blocker, tocilizumab, in atherosclerosis with diabetes. Human aortic smooth muscle cells (HASMCs) cultured under hyperglycemic conditions were evaluated for migration, expression of adhesion molecules, and matrix metalloproteinases before and after treatment with tocilizumab. High glucose (HG) significantly increased expression of IL-6, intercellular adhesion molecule (ICAM-1), matrix metalloproteinase-2 & 9, and migration of vascular smooth muscle cells. Tocilizumab suppressed HG-induced expression of ICAM-1, MMP-2, and MMP-9. Pretreatment with tocilizumab also inhibited migration, MAPK signaling, and nuclear translocation of p65-NF-kappa B in HG-stimulated HASMCs. Our data suggested that tocilizumab may exert an antiatherosclerotic activity in diabetes.
    link: http://dx.doi.org/10.1089/jir.2018.0009
    關聯: Cancers, v.38, n.11, pp.510-516
    顯示於類別:[高齡福祉養生管理系] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1384檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋